Cefuroxime Axetil Tablets 500 mg
CEFAERO-500 contains cefuroxime axetil, an oral second-generation cephalosporin antibiotic that is converted to active cefuroxime after administration.
Cefuroxime interferes with bacterial cell-wall synthesis, producing bactericidal activity against susceptible organisms. Its antibacterial spectrum includes selected Gram-positive and Gram-negative bacteria.
The 500 mg strength is used in certain established cefuroxime treatment regimens, including selected bacterial respiratory tract and skin infections. It is not automatically preferable to the 250 mg strength; the appropriate dose depends on the approved indication and individual clinical requirements.
Treatment should consider antimicrobial susceptibility, renal function and applicable prescribing recommendations.
Dosage Form: Tablets
Strength: 500 mg
Packing: 10 x 10 Alu Alu
Prescription medicine. Use under the supervision of a registered medical practitioner.
Oral cephalosporin antibiotic: Contains cefuroxime axetil, a second-generation cephalosporin.
Bactericidal action: Inhibits bacterial cell-wall synthesis.
Antibacterial activity: Active against selected susceptible Gram-positive and Gram-negative organisms.
500 mg tablet strength: Used in specific cefuroxime dosing regimens where clinically indicated.
Treatment considerations: Appropriate use depends on infection type, bacterial susceptibility, renal function and patient assessment.
Therapeutic Indications —
Acute Bacterial Exacerbation of Chronic Bronchitis: Treatment of selected infections caused by susceptible bacterial pathogens.
Uncomplicated Skin and Skin-Structure Infections: Treatment of infections caused by susceptible bacteria.
Early Lyme Disease: An indication included in certain international cefuroxime axetil 500 mg prescribing information
The 500 mg strength should not be presented as universally superior to 250 mg or as appropriate for every infection treated with cefuroxime.
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about CEFAERO-500 for professional use.